Empirical vs Tailored Therapy for H. Pylori Infection
Conditions: Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation; Helicobacter Pylori Infection Interventions: Combination Product: triple therapy; Combination Product: quadruple therapy; Diagnostic Test: dual-priming oligonucleotide-based multiplex (DPO)-PCR test Sponsor: Seoul National University Hospital Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials